Pharmaceutical Executive Daily: FDA Approves Pasatru

Aug 20, 03:36 PM
Headliner
Share
Subscribe

A partnership roundup covers deals from IntraGel Therapeutics/UroGen Pharma and Lupin/Tenpoint Therapeutics, FDA approves Regeneron's Pasatru for fibrodysplasia ossificans progressiva, and RELEX's Rohit Tripathi discusses reshoring pharma manufacturing.

Share
Subscribe
Next
Pharmaceutical Executive Daily: President Trump to Nominate Heidi Overton as FDA Commissioner
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Key Findings of the NIAGARA and HIMALAYA Trials
by Pharmaceutical Executive